Raymond James & Associates Merck & Co., Inc. Call Options Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 08, 2023	BUY	$87.44 - $112.11 $1.73 Million - $2.22 Million	19,800 Added 57.06%	54,500 $6.05 Million
Q3 2022 Oct 25, 2022	SELL	$84.53 - $94.96 $2.98 Million - $3.35 Million	-35,300 Reduced 50.43%	34,700 $28,000
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $4.25 Million - $4.82 Million	-50,900 Reduced 42.1%	70,000 $284,000
Q1 2022 May 11, 2022	BUY	$73.51 - $82.4 $7,351 - $8,240	100 Added 0.08%	120,900 $184,000
Q4 2021 Feb 08, 2022	BUY	$72.28 - $90.54 $520,416 - $651,888	7,200 Added 6.34%	120,800 $21,000
Q3 2021 Nov 02, 2021	BUY	$71.68 - $78.83 $50,176 - $55,181	700 Added 0.62%	113,600 $93,000
Q2 2021 Aug 11, 2021	SELL	$70.31 - $77.77 $1.12 Million - $1.24 Million	-15,900 Reduced 12.34%	112,900 $179,000
Q1 2021 May 14, 2021	SELL	$68.86 - $81.11 $3.66 Million - $4.31 Million	-53,100 Reduced 29.19%	128,800 $175,000
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $4.59 Million - $5.1 Million	64,000 Added 54.28%	181,900 $277,000
Q3 2020 Nov 04, 2020	BUY	$73.18 - $82.95 $1.5 Million - $1.7 Million	20,500 Added 21.05%	117,900 $125,000
Q2 2020 Jul 28, 2020	BUY	$70.42 - $80.13 $288,722 - $328,533	4,100 Added 4.39%	97,400 $17,000
Q1 2020 Apr 21, 2020	SELL	$63.36 - $87.82 $5.82 Million - $8.07 Million	-91,900 Reduced 49.62%	93,300 $24,000
Q4 2019 Feb 12, 2020	SELL	$77.58 - $87.54 $139,644 - $157,572	-1,800 Reduced 0.96%	185,200 $814,000
Q3 2019 Nov 07, 2019	BUY	$76.08 - $82.93 $829,272 - $903,937	10,900 Added 6.19%	187,000 $489,000
Q2 2019 Aug 06, 2019	BUY	$69.84 - $81.59 $76,824 - $89,749	1,100 Added 0.63%	176,100 $937,000
Q1 2019 May 06, 2019	SELL	$69.58 - $79.36 $90,454 - $103,168	-1,300 Reduced 0.74%	175,000 $984,000
Q4 2018 Feb 11, 2019	SELL	$65.24 - $75.71 $913,359 - $1.06 Million	-14,000 Reduced 7.36%	176,300 $646,000
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $265,374 - $312,064	-4,600 Reduced 2.36%	190,300 $598,000
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $5 Million - $5.88 Million	98,400 Added 101.97%	194,900 $170,000
Q1 2018 May 14, 2018	SELL	$50.96 - $59.23 $1.43 Million - $1.66 Million	-28,100 Reduced 22.55%	96,500 $37,000
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $2.95 Million - $3.52 Million	-57,100 Reduced 31.43%	124,600 $42,000
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $3.68 Million - $3.96 Million	62,800 Added 52.82%	181,700 $172,000
Q2 2017 Aug 14, 2017	BUY	N/A	118,900	118,900 $146,000

Others Institutions Holding MRK

# of Institutions

3,819

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$24.3 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$20.2 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$11.6 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.39 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$5.76 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account